Dive into the data behind the landmark nine-year TRACERx study into lung cancer 🔍 Professor Charles Swanton, the project’s lead researcher and our chief clinician, said: “The study recognises that cancer isn’t static – and the way we treat patients shouldn’t be either.” To make their discoveries, Professor Swanton’s team at The Francis Crick Institute and UCL looked at a huge range of people affected by lung cancer. That's why TRACERx involved over 800 participants at 13 UK hospital sites, and

Lung cancer is the second most common cancer in the UK, and more people are diagnosed at an advanced stage than an early stage. Watch and share our animation to find out the 10 things you need to know about lung cancer – from what it is, to the causes and key signs and symptoms. | Cancer Research UK